Risk effectiveness

A summary of several Web site sources that provide extensive data bases on the chemical and physical properties, as well as health risk effects associated with air contaminants. 

Evaluation of Diesel Unavailability and Risk Effective Surveillance Test Intervals Nuclear DG test and accident unavailability for 10 operating years Diesel generators 97. 

TITLE Evaluation of Diesel Unavailability and Risk Effective Surveillance... 

Freudenheim, J.L., Ambrosone, C.B., Moysich, K.B., Vena, J.E., Marshall, J.R., Graham, S., Laughlin, R., Nemoto, T. Shields, RG. (1997) Alcohol intake and breast cancer risk effect of alcohol metabolism by alcohol dehydrogenase (Abstract No. 4153). Proc. Am. Assoc. Cancer Res., 38, 619... 

One on-going study regarding health effects of barium was reported in the FEDRIP (1989) database. An epidemiological study is presently being conducted by L. Frohman. The relationship between barium in drinking water and the cardiovascular risk effects to humans is being assessed. No other... 

Exposure aspects of mixture risk Effects aspects of mixture risk Derivation of environmental quality criteria for mixtures... 

Social impacts, including health impacts, accident risks, effect on work environment and satisfaction of human needs. 

N. de Rons, Trans fatty acids, HDL-cholesterol, and cardiovascular disease risk Effects of dietary changes on vascular reactivity, Wageningen Universiteit, Wageningen, the Netherlands, 2001. 

Soderlund DM, Clark JM, Sheets LP, et al. Mechanisms of pyrethroid neurotoxicity Implications for cumulative risk effect. Toxicology 2002 171(1) 3-59. 

The risk assessment requires information about potential risks, effects, and impacts on current processes and environments. Process risk assessment is mainly determined by the probability of process interruption, system down times, and restart of a system. Typical chemical risk assessments comprise identification of hazards for personnel, customers, and environment, qualitative assessment of potential adverse consequences of the contaminant, and evidence of their significance. The previously described systems for toxicology estimation are useful software modules in this process. Environmental risks require additional dose-response assessments as well as quantification of exposure to determine the dose that individuals will receive. Einally, a qualitative assessment of the probability for recurrence of the exception is performed, or — in the case of systematic occurrence — the exception is linked to similar cases. 

Covello s report suggests a very useful list of what communication can do to effectively inform people about risk. Effective risk communication requires simplicity relevant, personalized comparisons an understanding of the audience complete honesty and a perspective that acknowledges political and ideological conflicts. 

The prevalence of toxic metal ions in contaminated aqueous and terrestrial environments represents a significant environmental risk. Effective pollution con-... 

HUMAN HEALTH RISKS Inhalation-human TCLo 134 ppm/30M EPA cancer risk level 5E mg/m EPA Group B2 probable human carcinogen Acute Risks irritation of skin, eyes and upper respiratory tract respiratory paralysis erythema coughing pulmonaiy edema necrosis. Chronic Risks effects on liver, kidneys, lungs, blood and CNS symptoms of chronic exposure resemble those of alcoholism. 

HUMAN HEALTH RISKS Inhalation human TCLo 570 mg/kg EPA RfC 0.05 mgW Acute Risks irritation of mucous membranes weakness nausea convulsions and death at concentrations higher than 500 ppm Chronic Risks effects on liver, kidneys and CNS cyanide poisoning including headaches, numbness and tremors dermatitis. 

HUMAN HEALTH RISKS EPA cancer risk level 9E-4 mg/m EPA group B2 probable human carcinogen Acute Risks CNS depression slowing of brain activities reddening of face areflexia convulsions dizziness headaches pulmonary edema shock amnesia irritation causing increases flow of tears and saliva Chronic Risks effects of liver, kidney and CNS lesions in tissues. 

HUMAN HEALTH RISKS EPA group C possible human carcinogen Acute Risks eye, skin, respiratory tract bums nasal constriction gastrointestinal effects throat and skin irritation Chronic Risks effects on blood, liver, kidneys, CNS abdominal pain tumors chemical pneumonitis digestive tract bums. 

HUMAN HEALTH RISKS Acute Risks salivation shortness of breath convulsions vertigo nausea Chronic Risks effects on brain, lungs, heart, CNS tremors loss of appetite deafness loss of muscle coordination respiratory and cardiovascular effects. 

HUMAN HEALTH RISKS Acute Risks irritation of eyes, mucous membranes, upper respiratory tract and skin gastrointestinal effects vomiting headaches pulmonary edema Chronic Risks effects on liver, eyes, kidneys, CNS and immune system may alter genetic material can cause male reproductive effects known carcinogen. 

HUMAN HEALTH RISKS EPA group B2 probable human carcinogen Inhalation human TCLo 470 ppm Acute Risks irritation of skin, eyes, nasal passages, throat and lungs dizziness headaches nausea coughing abdominal pain vomiting drowsiness Chronic Risks effects on kidneys, liver and CNS may alter genetic material hepatic and renal lesions. 

HUMAN HEALTH RISKS Inhalation human LCLo 60,000 ppm for 2 hours EPA Group D not classifiable as to human carcinogenicity Acute Risks destructive to skin, eyes, mucous membranes and respiratory tract dermatitis skin lesions spasm pulmonary edema shortness of breath respiratory effects vomiting blurred vision confusion Chronic Risks effects on eyes, liver, kidney, lungs cumulative effects. 

HUMAN HEALTH RISKS Inhalation human TCLo 100 ppm Acute Risks irritation of eyes, skin, mucous membranes and respiratory tract abdominal cramps confusion CNS depression narcosis vomiting headache dizziness dermatitis gastrointestinal problems Chronic Risks Effects on CNS, liver and respiratory system skin defattening dermatitis. 

HUMAN HEALTH RISKS EPA Group B2 probable human carcinogen Acute Risks burning of face and eyes gastrointestinal effects nausea kidney irritation cyanosis hematuria (blood in the urine) methemoglobinemia Chronic Risks effects on liver, blood and kidneys tumors in animals. 

HUMAN HEALTH RISKS Acute Risks irritation of eyes, skin, mucous membranes and upper respiratory tract cyanosis anoxia anemia methemoglobinuria lowering of consciousness CNS effects death Chronic Risks effects on blood, blood forming organs, CNS, male reproductive system, liver and spleen. 

HUMAN HEALTH RISKS Acute Risks headache dizziness lethargy ataxia weakness urinary burning acute hemorrhagic cystitis Chronic Risks effects on blood and bladder tumors in animals. 

HUMAN HEALTH RISKS EPA Group C possible human carcinogen Acute Risks irritation of eyes, nose and throat headaches dizziness nausea shortness of breath coma Chronic Risks effects on liver and kidneys. 

CHRONIC HEALTH RISKS effects on peripheral nervous system and central nervous system respiratory system effect liver damage. 

CHRONIC HEALTH RISKS effects on metabolism possibly causes toxic effects upon human reproduction. 

CHRONIC HEALTH RISKS effects on liver, blood, cardiovascular, and immune systems local sensitivity reactions EPA Group B2/C possible human carcinogen.. 

CHRONIC HEALTH RISKS effects on central nervous system weakness fatigue depression headache possible liver damage reproductive effects peripheral neuropathy effects on blood minor effects on kidney enzyme functions increased risk of leukemia increased risk of lymphoma EPA Group C possible human carcinogen. 

CHRONIC HEALTH RISKS effects on the liver, kidneys, and cardiovascular system immune system effects severe eye and skin irritant mutagen may alter genetic materials possible human carcinogen. 

---